Search

everythinglearnresearchcommunity

for

Search:↓

Rapid weight loss from dieting and hormonal injections can cause significant hair loss in women.

Thyroid hormone therapy effectively treated the man's rare muscle and heart issues.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Lower SHBG levels may increase the risk of PCOS.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Young adults with hair loss face higher risk of stiff arteries.

Testosterone helps human pancreatic cells increase insulin release.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Men with severe early-onset baldness may have worse heart artery function and stiffer arteries if they have high blood pressure.